In melanoma, tumor-MDSCs harbor higher activation of PERK, the deletion of which transformed MDSCs into myeloid cells that activated CD8+T cell-mediated immunity against tumor cells [62]. This evidence concerns the gene EIF2AK3 and neoplasm.